RT Journal Article
T1 Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study
A1 Martín Jiménez, Paloma
A1 Lalueza Blanco, Antonio
A1 Maestro De La Calle, Guillermo
A1 Folgueira López, María Dolores
A1 Pérez Martínez, David Andrés
A1 Villarejo Galende, Alberto
AB We analyzed the frequency of cognitive impairment (CI) in deceased COVID-19 patients at a tertiary hospital in Spain. Among the 477 adult cases who died after admission from March 1 to March 31, 2020, 281 had confirmed COVID-19. CI (21.1% dementia and 8.9% mild cognitive impairment) was a common comorbidity. Subjects with CI were older, tended to live in nursing homes, had shorter time from symptom onset to death, and were rarely admitted to the ICU, receiving palliative care more often. CI is a frequent comorbidity in deceased COVID-19 subjects and is associated with differences in care.
PB Sage Journals
SN 1387-2877
YR 2020
FD 2020
LK https://hdl.handle.net/20.500.14352/117605
UL https://hdl.handle.net/20.500.14352/117605
LA eng
NO 1. Martín-Jiménez P, Muñoz-García MI, Seoane D, et al. Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study. Journal of Alzheimer’s Disease. 2020;78(4):1367-1372. doi:10.3233/JAD-200937
DS Docta Complutense
RD 11 abr 2025